MRD / Regn No. : THBC\23-24\01340 Date : 09/06/2026
Patient Name : Krutarth Shah Age & Gender : 48 Yrs. / Male
Contact No. : 9320640424 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (03/Feb/2009) |
Subjective : T2DM- 15YRS,PNEUMONIA 2 EPISODES - VACCINATION COMPLETION PENDING,SWITCHING TO OZEMPIC
Objective : JUN-2026 REPORTS,FBS-122/ PPBS-133,TC-151/ TG-159/ LDL-65/ HDL-54,ALT-40/ AST-23,HBA1C-7.5%,ACR-76.71
Analysis : DOES NOT TOLERATE DAPAGLIFLOZIN
Plan : HBA1C > 2 MTHS - TO DECIDE WHETHER DOSE INCREMENT  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET PIOGLITAZONE 7.5MG
PIOZ 7.5 MG 		ORAL 1-0-0 BBF
 4 MTHS
2 GLYCOMET GP2 ORAL 1-0-0 BBF
 4 MTHS
3 GLYCOMET GP1 ORAL 0-0-1 BD
 4 MTHS
4 INJ OZEMPIC 0.5 MG SC 0.5 MG / WEEK ANYTIME OF DAY
 4 WEEKS
5 INJ OZEMPIC 1 MG SC DAILY ANYTIME OF DAY
 4 WEEKS
       
Refill : 0 / Substitution:    
Education : IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.
Next Visit : 10/Jun/2026
Tests Suggested For Next Visit : HBA1C / FBS / PPBS / LFT / LIPID PROFILE > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: